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Using a sensitive RNase protection assay, we have measured the levels of P-glycoprotein mRNA in fourteen different 
Chinese hamster tissues and in three cell lines to determine whether a relationship exists between the level of P-glyco- 
protein expression and the occurrence of primary and acquired multidrug resistance (MDR) in cancer. P-Glycoprotein 
mRNA was detected in all tissues, suggesting that the protein is a normal constituent of the cell. High levels of P-glycopro- 
tein mRNA were found in oesophagus, testis and uterus. Intermediate levels in brain, lung and ovary, and a very low 
level in the adrenal gland, bladder, bone marrow, heart, kidney, liver and spleen. There is no obvious correlation between 
this expression pattern and the occurrence of primary or acquired MDR. 
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1. INTRODUCTION 
Chemotherapy .is often not effective in the treat- 
ment of cancer, as some tumors are intrinsically 
resistant o chemotherapeutic agents (primary drug 
resistance), whereas other tumors can acquire 
resistance (secondary drug resistance). Treatment 
with one drug may result in the acquisition of 
resistance to a wide variety of drugs, including 
structurally and functionally, unrelated drugs 
(review [l]). This multidrug resistance (MDR) is 
mediated by the overexpression of a 170 kDa 
membrane protein, the P-glycoprotein [2-41. This 
protein helps to keep the intracellular drug concen- 
tration low, probably by an active transport of 
drugs out of the cell [l]. Sequence analysis of 
human, mouse and hamster P-glycoprotein 
cDNAs has revealed a high degree of homology of 
the P-glycoprotein to bacterial transport proteins 
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[3,5,6], supporting the hypothesis that the P- 
glycoprotein is involved in the active transport of 
drugs across the cell membrane (review [7]). Since 
not all tumors are equally sensitive to drugs, we 
were interested in determining the basal level of P- 
glycoprotein, expression in normal tissue. Con- 
stitutive high levels of expression could explain 
primary drug resistance or susceptibility to develop 
MDR. In addition, the expression pattern of the P- 
glycoprotein genes might also give a clue to the 
function of the P-glycoprotein in normal cellular 
metabolism. Our previous analysis of Chinese 
hamster ovary and lung cell lines showed very low 
levels of P-glycoprotein gene expression [8,9]. We 
have therefore used a sensitive and quantitative 
method, RNase protection, to determine the levels 
of P-glycoprotein mRNA [lo] in hamster tissues. 
2. MATERIALS AND METHODS 
2.1. RNA isolation and quantitative RNase mapping 
RNA was isolated by the LiCl-urea method [ll]. RNA 
samples were quantitated and checked for integrity by elec- 
trophoresis through 0.8% agarose gels. 10,ug of total RNA of 
each organ and cell line was hybridized with’RNA probes under 
standard conditions [lo] and treated with RNase A. The pro- 
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tected fragments were visualized by electrophoresis through 
denaturing acrylamide gels followed by autoradiography. 
2.2. RNA probes 
The plasmid CP22s contains a XhoI-BanrHI fragment of 370 
nucleotides (nt) from the 3’-coding region of a hamster P- 
glycoprotein cDNA cp22 [8] subcloned between the BumHI and 
Hind111 sites of pGEM2 (Promega Biotech). Since the vector 
used contains both an SP6 and T, RNA polymerase promotor, 
RNA probes for the sense and anti-sense strand could be syn- 
thesized from one plasmid. cRNA was synthesized from linear 
templates according to [lo]. For sense strand synthesis, the 
plasmid was linearized with PvuII and transcribed with SP6 
RNA polymerase. The anti-sense strand was made using an 
EcoRI linearized template and T7 RNA polymerase. Since both 
probes contain transcribed plasmid vector sequences at their 5 ’ - 
and 3’-end, a distinction can be made between non-digested 
probe and probe protected by cellular RNA. 
3. RESULTS AND DISCUSSION 
The P-glycoprotein gene is part of a gene family, 
with at least three transcribed members in hamster 
and two in man [9,12-141. Sequence analysis of 
cDNA clones shows that the different mRNAs are 
conserved near the 3 ’ -end of the coding sequence 
[12]. We have used a cDNA fragment from this 
conserved region as probe in our assay. The probe, 
CP22s, corresponds to the transmembrane seg- 
ment 6a and the nucleotide binding site (positions 
755-1125 [12]) of the hamster P-glycoprotein gene 
originally designated gene class 2C [ 1 l] and recent- 
ly renamed pgpl [12]. pgpl is the homologue of 
the human mdrl gene. The similarity with the 
hamster equivalent of the human mdr3 gene [ 131 is 
unknown. 
Total RNA was isolated from Chinese hamster 
oesophagus, heart, uterus, liver, striated muscle, 
adrenal gland, kidney, lung, brain, bone marrow, 
testis, spleen, bladder and ovary. We have also 
used the Chinese hamster cell lines Aux BI (ovary), 
CHRCS (MDR ovary) and A3 (fibroblast). To 
even out individual variation in P-glycoprotein ex- 
pression between animals we have pooled organs 
from six different animals and to avoid polymor- 
phism between the different animals, an inbred 
Chinese hamster strain was used. 
An example of the RNase protection assay is 
shown in fig. 1. Lanes A-F show an RNase protec- 
tion experiment with RNA derived from testis, 
uterus, the fibroblast cell line A3 and from the 
ovarium cell line Aux Bl and the MDR cell line 
derived from it (CHRCS) [15]. For clarity, the 
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Fig.1. P-glycoprotein mRNA levels in various tissues. Lanes 
A-E show a 96 h exposure of RNase protection of Aux BI (lane 
A), the cell line A3 (B), testis (C), uterus (D) and tRNA (E) 
respectively hybridized with an anti-sense probe. For clarity, the 
lane corresponding to CHRCS RNA has been removed from the 
left panel and a 4 h exposure is shown in lane F. As size marker 
a radioactively labelled MspI digest of pAT153 was used (lane 
M). The position of the protected fragment corresponding to 
thepgpl transcript is indicated by an arrow. For each lane 10 pg 
of RNA was used. 
CHRCS RNA lane (F) was exposed for only 4 h, 
whereas the other lanes were exposed for 96 h. The 
Aux BI (A), A3 (B) and CHRCS RNA (F) lanes 
show a band of the expected size (370 nt, indicated 
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by the arrow); in addition, two other major frag- 
ment are visible (210, 160 nt). These additional 
bands most likely reflect minor differences be- 
tween the different P-glycoprotein mRNA species 
(see below). None of these bands are detected after 
hybridization with tRNA (lane E) and they are thus 
specific for P-glycoprotein mRNA. Hybridization 
or RNase digestion at other temperatures or using 
other RNase A concentrations did not significantly 
alter the ratio of the expected protected fragments 
and these additional bands. As a control, all 
hybridizations were also performed using the sense 
probe and as expected, no fragments were pro- 
tected (not shown). This shows that our assay is 
completely specific and that the hamster P- 
glycoprotein genes are only transcribed to a signifi- 
cant extent in one direction. 
RNA from the Chinese hamster tissues yields 
another set of fragments. As examples, the signals 
obtained with testis and uterus RNA are shown in 
fig.1, lanes C and D. Since the same set of 
fragments is detected in all 14 tissues, we conclude 
that the difference in pattern detected between the 
cell lines and Chinese hamster tissues is due to 
polymorphic variation between the Chinese 
hamster strain and the cell lines used. No 
fragments are detected in any of the tissues by the 
sense probe. The result of our analysis is sum- 
marized in table 1. P-glycoprotein mRNA levels 
are expressed using the CHO cell line Aux BI as an 
arbitrary standard. The difference in P- 
glycoprotein expression between Aux BI and 
CHRCS is in agreement with our previous results 
PI. 
The method used here to measure P- 
glycoprotein gene expression is more sensitive and 
specific than RNA blot hybridization, but it may 
underestimate expression of the P-glycoprotein 
gene family for three reasons: (i) the pgpl probe 
used will not yield protected fragments of 370 nt 
with transcripts from the pgp2 and pgp3 genes. 
The pgp2 transcripts in Aux BI contain a stretch 
of 160 nt in which only 4 single bases mismatching 
pgp2 are present (positions 973-l 125 [12]), flank- 
ed by a 3 nt mismatch. Since single basepair 
mismatches are not easily detected by RNase pro- 
tection, the 160 nt fragment detected in Aux BI, 
A3 and CHRCS RNA most likely reflects the pgp2 
transcript. The pgp3 sequence is not yet available, 
but in view of the divergence between the human 
Table 1 
Tissue/cell line Relative expression 
Adrenal gland + 
Bladder + 





Striated muscle + 
A3 ++ 








Expression of the P-glycoprotein gene in Chinese hamster 
organs and cell lines. The P-glycoprotein mRNA levels are 
expressed relative to the level in the CHO cell line Aux BI. 
Expression is measured as radioactivity in the bands > 100 nt 
in gels as shown in fig. 1. Expression levels were determined by 
comparing band intensities on different autoradiographic 
exposures with a dilution series of a RNase protection 
experiment. +, <O.l; + +, 0.1-l; + + +, l-10; + + + + , 
>lOO 
m&l and mdr3 sequence [ 131, the probe used 
might not detect the pgp3 transcripts. (ii) We have 
recently shown that at least one of the human mdr 
genes, mdr3, which is equivalent to pgp3 is alter- 
natively spliced [13]. Alternative splicing of pgpl 
and pgp2 may lead to an underestimation of the 
expression levels of these genes. (iii) There could be 
differences between the pgpl gene in the CHO cell 
line from which the probe is derived and the inbred 
strain of Chinese hamsters from which the tissue 
RNAs were prepared. This seems the most likely 
explanation for the absence of the 370 nt fragment 
after hybridization with the tissue RNAs, whereas 
this fragment is detected in the cell line RNAs. 
Hence, the high levels in table 1 are certainly 
significant, but low levels may be due to the limita- 
tions of the probe used. 
The results in table 1 provide no clue to the 
nature of the normal function of P-glycoproteins 
or their contribution to primary drug resistance of 
mammalian tumors. High expression is found in 
testis, oesophagus and uterus. These organs are 
not derived from a common embryonic structure, 
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nor do they share an abundant common cell type. 
Testis and uterus also do not yield tumors that are 
particularly drug resistant. More information may 
come from in situ hybridization to resolve P- 
glycoprotein mRNA levels of individual cells in 
each of these tissues. 
Notwithstanding these limitations it is of interest 
to compare our results with those of Fojo et al. 
[ 161, who recently measured mdrl mRNA levels in 
human tissues by a slot blot hybridization pro- 
cedure. In human tissues, the authors find the 
highest levels in the adrenal gland, somewhat lower 
levels in kidney, colon, liver, lung, jejunum and 
rectum; even lower levels in brain and prostate; 
and the lowest levels in skin, subcutaneous tissue, 
skeletal muscle, heart, spleen, bone marrow, lym- 
phocytes, oesophagus, stomach, uterus, renal cor- 
tex and spinal cord. The most remarkable 
differences are in the mRNA content of liver, 
adrenal gland (high in man, low in hamster) and 
oesophagus (low in man, high in hamster). We 
have verified that the high levels in human adrenal 
gland and liver are indeed due to mdrl expression 
and not to the expression of the mdr3 gene, which 
may have been missed in the hamster experiments 
(Lincke, C., Van der Bliek, A. and Borst, P., un- 
published). Moreover, Fojo et al. [16] detect a low 
mdrl mRNA level in the rat adrenal gland with the 
probe that gives high levels in human adrenals. 
This suggests that substantial species differences 
exist in the tissue specificity of P-glycoprotein gene 
expression. 
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